BioXcel Therapeutics, Inc. (BTAI)
NASDAQ·Healthcare·Biotechnology
$1.16
+4.50%
Mkt Cap $29.51M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$12.00
Range $1.00 – $25.00
Implied Upside
+934.5%
Consensus $12.00 vs current $1.16
NASDAQ·Healthcare·Biotechnology
$1.16
+4.50%
Mkt Cap $29.51M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$12.00
Range $1.00 – $25.00
+934.5%
Consensus $12.00 vs current $1.16